Treatment Outcomes Under a Standardized Treatment Protocol in Patients Suffered Substance Abuse Related Voiding Dysfunction

Launched by CHINESE UNIVERSITY OF HONG KONG · Apr 10, 2019

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment approach for people who have developed bladder problems due to substance abuse, particularly from drugs like ketamine and methamphetamine. The researchers want to see if a standardized treatment plan can help these patients manage their symptoms better. The treatment includes education about the condition, medications to reduce pain and inflammation, and possibly more advanced treatments if initial medications do not work. For those with severe and persistent symptoms, surgical options may be considered.

To be eligible for this trial, participants must have bladder issues caused by substance abuse. They also need to agree to the treatment protocol and be willing to participate. The trial is currently looking for participants of all ages and genders. Those who join can expect to receive comprehensive care aimed at improving their bladder function while monitoring for any side effects from the medications used. This research aims to provide more effective treatment options for a condition that currently lacks clear guidelines.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients suffered substance abuse induced voiding dysfunction
• Exclusion Criteria:
• • Patient not agreed for consent
• • Patient that will not comply to our treatment protocol